Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Ekso Bionics Holdings (EKSO) Treasury Shares (2024 - 2026)

Ekso Bionics Holdings has reported Treasury Shares over the past 3 years, most recently at $86000.0 for Q4 2025.

On a quarterly basis, Treasury Shares rose 26.47% to $86000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $86000.0, a 26.47% increase, with the full-year FY2025 number at $86000.0, up 26.47% from a year prior.
Treasury Shares reached $86000.0 in Q4 2025 per EKSO's latest filing, down from $100000.0 in the prior quarter.
The five-year high for Treasury Shares was $836000.0 in Q1 2025, with the low at $68000.0 in Q4 2024.